|
1
|
Morshed K, Polz-Dacewicz M, Szymański M
and Polz D: Short-fragment PCR assay for highly sensitive
broad-spectrum detection of human papillomaviruses in laryngeal
squamous cell carcinoma and normal mucosa: clinico-pathological
evaluation. Eur Arch Otorhinolaryngology. 265(Suppl 1): S89–S96.
2008. View Article : Google Scholar
|
|
2
|
Chen K, Song F, He M, Li H, Qian B, Zhang
W, Wei Q and Hao X: Trends in head and neck cancer incidence in
Tianjin, China, between 1981 and 2002. Head Neck. 31:175–182. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cattaruzza MS, Maisonneuve P and Boyle P:
Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol.
32B:293–305. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang M, Li W, Liu YY, Fu S, Qiu GB, Sun KL
and Fu WN: Promoter hypermethylation-induced transcriptional
down-regulation of the gene MYCT1 in laryngeal squamous cell
carcinoma. BMC Cancer. 12:2192012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Toporcov TN, Znaor A, Zhang ZF, Yu GP,
Winn DM, Wei Q, Vilensky M, Vaughan T, Thomson P, Talamini R, et
al: Risk factors for head and neck cancer in young adults: a pooled
analysis in the INHANCE consortium. Int J Epidemiol. 44:169–185.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laird PW: Cancer epigenetics. Hum Mol
Genet. 14:R65–R76. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang D, Hong Q, Shen Y, Xu Y, Zhu H, Li
Y, Xu C, Ouyang G and Duan S: The diagnostic value of DNA
methylation in leukemia: a systematic review and meta-analysis.
PloS One. 9:e968222014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang T, Chen X, Hong Q, Deng Z, Ma H, Xin
Y, Fang Y, Ye H, Wang R, Zhang C, et al: Meta-analyses of gene
methylation and smoking behavior in non-small cell lung cancer
patients. Sci Rep. 5:88972015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang D, Shen Y, Dai D, Xu Y, Xu C, Zhu H,
Huang T and Duan S: Meta-analyses of methylation markers for
prostate cancer. Tumour Biol. 35:10449–10455. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aran D, Toperoff G, Rosenberg M and
Hellman A: Replication timing-related and gene body-specific
methylation of active human genes. Hum Mol Genet. 20:670–680. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L, Zheng D, Wang L, Jiang D, Liu H, Xu
L, Liao Q, Zhang L, Liu P, Shi X, et al: GCK gene-body
hypomethylation is associated with the risk of coronary heart
disease. Biomed Res Int. 2014:1517232014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sporn MB and Roberts AB: Transforming
growth factor-beta: recent progress and new challenges. J Cell
Biol. 119:1017–1021. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bierie B and Moses HL: Tumour
microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Nat Rev Cancer. 6:506–520. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu L, Kron KJ, Pethe VV, Demetrashvili N,
Nesbitt ME, Trachtenberg J, Ozcelik H, Fleshner NE, Briollais L,
van der Kwast TH and Bapat B: Association of tissue promoter
methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate
cancer progression. Int J Cancer. 129:2454–2462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leo E, Mancini M, Aluigi M, Castagnetti F,
Martinelli G, Barbieri E and Santucci MA: DNA hypermethylation
promotes the low expression of pro-apoptotic BCL2L11 associated
with BCR-ABL1 fusion gene of chronic myeloid leukaemia. Br J
Haematol. 159:373–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dunwell T, Hesson L, Rauch TA, Wang L,
Clark RE, Dallol A, Gentle D, Catchpoole D, Maher ER, Pfeifer GP
and Latif F: A genome-wide screen identifies frequently methylated
genes in haematological and epithelial cancers. Mol Cancer.
9:442010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang L, Ye H, Hong Q, Wang L, Wang Q, Wang
H, Xu L, Bu S, Zhang L, Cheng J, et al: Elevated CpG island
methylation of GCK gene predicts the risk of type 2 diabetes in
Chinese males. Gene. 547:329–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Torrisani J, Hanoun N, Laurell H, Lopez F,
Maoret JJ, Souque A, Susini C, Cordelier P and Buscail L:
Identification of an upstream promoter of the human somatostatin
receptor, hSSTR2, which is controlled by epigenetic modifications.
Endocrinology. 149:3137–3147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ball MP, Li JB, Gao Y, Lee JH, LeProust
EM, Park IH, Xie B, Daley GQ and Church GM: Targeted and
genome-scale strategies reveal gene-body methylation signatures in
human cells. Nat Biotechnol. 27:361–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J, Zhu XB, He LX, Gu ZW, Jin MZ and
Ji WY: Clinical significance of epigenetic silencing and
re-expression of O6-methylguanine-DNA methyltransferase using
epigenetic agents in laryngeal carcinoma. Oncol Lett. 9:35–42.
2015.PubMed/NCBI
|
|
21
|
Kis A, Tatár TZ, Gáll T, Boda R, Tar I,
Major T, Redl P, Gergely L and Szarka K: Frequency of genetic and
epigenetic alterations of p14ARF and p16INK4A in head and neck
cancer in a Hungarian population. Pathol Oncol Res. 20:923–929.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Chen H, Fu S, Xu ZM, Sun KL and Fu
WN: The involvement of CHD5 hypermethylation in laryngeal squamous
cell carcinoma. Oral Oncol. 47:601–608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin D and Dong M: Methylation of promoter
and expression of FHIT gene in laryngeal squamous cell carcinoma.
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 19:253–255, 258. 2005.(In
Chinese). PubMed/NCBI
|
|
24
|
Suzuki MM and Bird A: DNA methylation
landscapes: provocative insights from epigenomics. Nat Rev Genet.
9:465–476. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kron K, Pethe V, Briollais L, Sadikovic B,
Ozcelik H, Sunderji A, Venkateswaran V, Pinthus J, Fleshner N, van
der Kwast T and Bapat B: Discovery of novel hypermethylated genes
in prostate cancer using genomic CpG island microarrays. PloS One.
4:e48302009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hinshelwood RA, Huschtscha LI, Melki J,
Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA,
Reddel RR and Clark SJ: Concordant epigenetic silencing of
transforming growth factor-beta signaling pathway genes occurs
early in breast carcinogenesis. Cancer Res. 67:11517–11527. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cho Y, Turner ND, Davidson LA, Chapkin RS,
Carroll RJ and Lupton JR: Colon cancer cell apoptosis is induced by
combined exposure to the n-3 fatty acid docosahexaenoic acid and
butyrate through promoter methylation. Exp Biol Med (Maywood).
239:302–310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
San Jose-Eneriz E, Agirre X,
Jimenez-Velasco A, Cordeu L, Martín V, Arqueros V, Gárate L,
Fresquet V, Cervantes F, Martínez-Climent JA, et al: Epigenetic
down-regulation of BIM expression is associated with reduced
optimal responses to imatinib treatment in chronic myeloid
leukaemia. Eur J Cancer. 45:1877–1889. 2009. View Article : Google Scholar : PubMed/NCBI
|
